Cargando…

Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis

BACKGROUND & AIMS: Various studies have investigated the relationship between the polymorphism, rs2596542, in the promoter of the major histocompatibility complex class I-related gene A (MICA) gene with susceptibility to hepatitis B virus (HBV)/ hepatitis C virus (HCV)-induced hepatocellular car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xiaojun, Wang, Yu, Shen, Ai, Deng, Hejun, Ye, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697945/ https://www.ncbi.nlm.nih.gov/pubmed/31419949 http://dx.doi.org/10.1186/s12881-019-0871-2

Ejemplares similares

SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis
por: Wang, Haichuan, et al.
Publicado: (2019)

Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis
por: Kuang, Xue-Jun, et al.
Publicado: (2019)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk
por: Lo, Paulisally Hau Yi, et al.
Publicado: (2013)

Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases
por: Mohamed, Amal A., et al.
Publicado: (2017)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma
por: Li, Hongguang, et al.
Publicado: (2016)

Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV‐related hepatocellular carcinoma in a Guangxi population
por: Lu, Yu, et al.
Publicado: (2020)

The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis
por: Qin, Shaoyou, et al.
Publicado: (2019)

Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases
por: Wang, Qingwen, et al.
Publicado: (2015)

Association of IFNL3 rs12979860 polymorphism with HCV-related hepatocellular carcinoma susceptibility in a Chinese population
por: Hou, Wei, et al.
Publicado: (2019)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection
por: Chen, Fei, et al.
Publicado: (2016)

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

Analysis of the association between MICA gene polymorphisms and schizophrenia
por: Ren, Xing, et al.
Publicado: (2022)

Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy
por: Motomura, Takashi, et al.
Publicado: (2012)

FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
por: Pineda-Tenor, Daniel, et al.
Publicado: (2014)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma
por: Petruzziello, Arnolfo
Publicado: (2018)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
por: Sun, Suofeng, et al.
Publicado: (2019)

Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective
por: Giannakoulis, Vassilis G., et al.
Publicado: (2021)

Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections
por: Sabry, Hany S., et al.
Publicado: (2021)

UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
por: Stücker, I, et al.
Publicado: (2007)

Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status
por: Xu, Yaxin, et al.
Publicado: (2022)

Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study
por: Onyeaghala, Guillaume, et al.
Publicado: (2019)

MICA*049, not MICA*009, is associated with Behçet’s disease in a Chinese population
por: Zhu, Weifeng, et al.
Publicado: (2019)

Von Hippel-Lindau gene single nucleotide polymorphism (rs1642742) may be related to the occurrence and metastasis of HBV-related hepatocellular carcinoma
por: Chen, Xuebing, et al.
Publicado: (2021)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients
por: Baek, In-Cheol, et al.
Publicado: (2018)

Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma
por: Zhu, Shao-Liang, et al.
Publicado: (2016)

Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma
por: Chang, Ming-Ling, et al.
Publicado: (2013)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
por: Wu, Hui-Chen, et al.
Publicado: (2021)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

Leukocyte Telomere Length-Related rs621559 and rs398652 Genetic Variants Influence Risk of HBV-Related Hepatocellular Carcinoma
por: Pan, Wenting, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o7dp78k6pfhn9g60eo0qsjrnn6